Noncommunicable diseases,Cardiovascular disease,Diabetes mellitus,Cancer,Lifestyle," /> Noncommunicable diseases,Cardiovascular disease,Diabetes mellitus,Cancer,Lifestyle,"/>
Journal of Integrative Medicine ›› 2017, Vol. 15 ›› Issue (4): 265-269.doi: 10.1016/S2095-4964(17)60355-8
Special Issue: Natural Drug
• Global Views • Previous Articles Next Articles
Chun-song Hua, Tengiz Tkebuchavab
| 1 1 World Health Organization. World health statistics 2016: monitoring health for the SDGs. (2017) [2017-01-07]. 2017) [2017-01-07]. http://www.who.int/gho/publications/world_health_ statistics/2016/en/.
2 Chen WW, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, Wu ZS, Li HJ, Gu DF, Yang YJ, Zheng Z, Jiang LX, Hu SS.China cardiovascular diseases report 2015: a summary.
3 Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults.
4 Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J.Cancer statistics in China, 2015.
5 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.BD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
6 6 World Health Organization. Environment behind nearly quarter of global deaths. (2016-03-16) [2017-01-07]. . Environment behind nearly quarter of global deaths. (2016-03-16) [2017-01-07]. http:// www.egyptindependent.com/environment-behind-nearlyquarter- global-deaths-who/.
7 Nan Y, Xi Z, Yang Y, Wang LL, Tu M, Wang JJ, Jiang Y.The 2015 China adult survey: exposure to secondhand smoke among adults aged 15 and above and their support to policy on banning smoking in public places.
8 NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1 698 population-based measurement studies with 19.2 million participants.
9 Wang W, Hu SS, Kong LZ, Gao RL, Zhu ML, Wang WY, Wu ZS, Chen WW, Yang JG, Ma LY, Liu MB; Editorial Board.Summary of report on cardiovascular diseases in China, 2012.
10 NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.
11 Hu CS, Wu QH, Hu DY.Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications.
12 Koene RJ, Prizment AE, Blaes A, Konety SH.Shared risk factors in cardiovascular disease and cancer.
13 Hu CS.RT-ABCDE strategy for management and prevention of human diseases.
14 Hu CS, Wu Q.Health: a dream from reality to the future.
15 Hu CS, Han YL, Ge JB, Wu QH, Liu YN, Ma CS, Tkebuchava T, Hu DY.A novel management program for hypertension.
16 Hu CS, Tkebuchava T.New “P” in medical model.
17 Tan J, Li N, Gao J, Guo Y, Hu W, Yang J, Yu B, Yu J, Du W, Zhang W, Cui L, Wang Q, Xia X, Li J, Zhou P, Zhang B, Liu Z, Zhang S, Sun L, Liu N, Deng R, Dai W, Yi F, Chen W, Zhang Y, Xue S, Cui B, Zhao Y, Wang L.Construction of the Chinese Veteran Clinical Research (CVCR) platform for the assessment of non-communicable diseases.
18 Hu C.SEEDi: Basic strategies for the primary and secondary prevention of atherosclerotic cardiovascular disease.
19 Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians.
20 David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ.Diet rapidly and reproducibly alters the human gut microbiome.
21 Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, Wang J, Imhann F, Brandsma E, Jankipersadsing SA, Joossens M, Cenit MC, Deelen P, Swertz MA; LifeLines cohort study, Weersma RK, Feskens EJ, Netea MG, Gevers D, Jonkers D, Franke L, Aulchenko YS, Huttenhower C, Raes J, Hofker MH, Xavier RJ, Wijmenga C, Fu J. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity.
22 Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A, Bonder MJ, Valles-Colomer M, Vandeputte D, Tito RY, Chaffron S, Rymenans L, Verspecht C, De Sutter L, Lima-Mendez G, D’hoe K, Jonckheere K, Homola D, Garcia R, Tigchelaar EF, Eeckhaudt L, Fu J, Henckaerts L, Zhernakova A, Wijmenga C, Raes J.Population-level analysis of gut microbiome variation.
23 Du H, Li L, Bennett D, Guo Y, Key TJ, Bian Z, Sherliker P, Gao H, Chen Y, Yang L, Chen J, Wang S, Du R, Su H, Collins R, Peto R, Chen Z; China Kadoorie Biobank Study. Fresh fruit consumption and major cardiovascular disease in China.
24 Wu S, Powers S, Zhu W, Hannun YA.Substantial contribution of extrinsic risk factors to cancer development.
25 Hu CS, Tkebuchava T.Structure-editing: a new branch?
26 McCarthy M. US president endorses “moonshot” effort to cure cancer.
27 Kaiser J, Couzin-Frankel J. BIOMEDICAL RESEARCH.Biden seeks clear course for his cancer moonshot.
28 Horwitz RI.Equity in cancer care and outcomes of treatment: a different type of cancer moonshot.
29 Stevens W, Peneva D, Li JZ, Liu LZ, Liu G, Gao R, Lakdawalla DN.Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.
30 Obama B.United States health care reform: progress to date and next steps.
31 Zang QQ, Zhang L, Gao N, Huang C.Ophiopogonin D inhibits cell proliferation, causes cell cycle arrest at G2/M, and induces apoptosis in human breast carcinoma MCF-7 cells.
|||Theocharis Koufakis, Kalliopi Kotsa, Nikolaos Papanas. Remission of type 2 diabetes depends on prompt comprehensive lifestyle changes upon diagnosis: How can this “Road to Damascus” experience be supported?. Journal of Integrative Medicine, 2022, 20(4): 288-291.|
|||Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.|
|||Jing Hong, Xiao-wan Xu, Jing Yang, Jing Zheng, Shu-mei Dai, Ju Zhou, Qing-mei Zhang, Yi Ruan, Chang-quan Ling. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey. Journal of Integrative Medicine, 2022, 20(1): 34-44.|
|||Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.|
|||Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.|
|||Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.|
|||Hao Gou, Ruo-chen Huang, Yong-hua Su, Wei Li. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer. Journal of Integrative Medicine, 2021, 19(5): 408-417.|
|||Liang Ding, Xin-you Zhang, Di-yao Wu, Meng-ling Liu. Application of an extreme learning machine network with particle swarm optimization in syndrome classification of primary liver cancer. Journal of Integrative Medicine, 2021, 19(5): 395-407.|
|||Eric Wei Chiang Chan, Siu Kuin Wong, Hung Tuck Chan. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots. Journal of Integrative Medicine, 2021, 19(4): 311-316.|
|||Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.|
|||Yunita Sari, Akhyarul Anam, Annas Sumeru, Eman Sutrisna. The knowledge, attitude, practice and predictors of complementary and alternative medicine use among type 2 diabetes mellitus patients in Indonesia. Journal of Integrative Medicine, 2021, 19(4): 347-353.|
|||Yue-jiao Shi, Hua-xian Zheng, Zhu-ping Hong, Han-bo Wang, Ying Wang, Ming-yan Li, Zhen-hao Li. Antitumor effects of different Ganoderma lucidum spore powder in cell- and zebrafish-based bioassays. Journal of Integrative Medicine, 2021, 19(2): 177-184.|
|||Dastan M. Khoshnaw, Abhijit A. Ghadge. Yoga as a complementary therapy for metabolic syndrome: A narrative review. Journal of Integrative Medicine, 2021, 19(1): 6-12.|
|||Pukar Khanal, Basanagouda M. Patil. Integration of network and experimental pharmacology to decipher the antidiabetic action of Duranta repens L.. Journal of Integrative Medicine, 2021, 19(1): 66-77.|
|||Li-qing Zhu, Li Zhang, Jia Zhang, Guo-lin Chang, Gang Liu, Dan-dan Yu, Xiao-min Yu, Mi-sheng Zhao, Bin Ye. Evodiamine inhibits high-fat diet-induced colitis-associated cancer in mice through regulating the gut microbiota. Journal of Integrative Medicine, 2021, 19(1): 56-65.|